Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
ACM Research, Inc. (ACMR) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ACM Research, Inc. (ACMR) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for February 8th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 8:
Post Holdings, Inc. (POST - Free Report) : This consumer-packaged goods holding company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.2% over the last 60 days.
Post Holdings, Inc. Price and Consensus
Post Holdings, Inc. price-consensus-chart | Post Holdings, Inc. Quote
Post Holdings' shares gained 24% over the last three months compared with the S&P 500’s advance of 13.8%. The company possesses a Momentum Score of A.
Post Holdings, Inc. Price
Post Holdings, Inc. price | Post Holdings, Inc. Quote
Inhibikase Therapeutics, Inc. (IKT - Free Report) : This pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16% over the last 60 days.
Inhibikase Therapeutics, Inc. Price and Consensus
Inhibikase Therapeutics, Inc. price-consensus-chart | Inhibikase Therapeutics, Inc. Quote
Inhibikase Therapeutics' shares gained 172.1% over the last three months compared with the S&P 500’s advance of 13.8%. The company possesses a Momentum Score of A.
Inhibikase Therapeutics, Inc. Price
Inhibikase Therapeutics, Inc. price | Inhibikase Therapeutics, Inc. Quote
ACM Research, Inc. (ACMR - Free Report) : This semiconductor equipment company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 60 days.
ACM Research, Inc. Price and Consensus
ACM Research, Inc. price-consensus-chart | ACM Research, Inc. Quote
ACM Research's shares gained 23.1% over the last six months compared with the S&P 500’s advance of 10.9%. The company possesses a Momentum Score of A.
ACM Research, Inc. Price
ACM Research, Inc. price | ACM Research, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.